Unavailability of pharmaceuticals in Slovakia?

According to the Slovak Association of Pharmaceutical Companies oriented on Research and Development there is a threat of economical unavailability of some pharmaceuticals in Slovakia. This may be due to the Decree on the method of determining a standard dose of the pharmaceutical, which determines the substitutability of groups of pharmaceuticals and states the so called group payment, where the amount of payment from insurance company is set by the lowest price of pharmaceutical in the group. According to the representatives of pharmaceutical industry its result is that there are top pharmaceuticals in one group together with obsolete ones, while insurance company pays the same price for all of them.